Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.37 |
| ▸ | RARB | P10826 | 3/20 | 0.37 |
| ▸ | CCNK | O75909 | 1/20 | 0.37 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9524995 | 1.00 | KDM4E (0.38) | KDM4EALDH1A1HPGDHTTL3MBTL1 | |
| SCHEMBL9524889 | 0.88 | ADRA1D (0.42) | KDM4EALDH1A1HPGDHTTL3MBTL1 | |
| SCHEMBL7502807 | 0.88 | ADRA1D (0.42) | KDM4EALDH1A1HPGDHTTL3MBTL1 | |
| SCHEMBL9523941 | 0.87 | MAPK14 (0.37) | KDM4EALDH1A1HPGDHTTL3MBTL1 | |
| SCHEMBL9523936 | 0.87 | MAPK14 (0.37) | KDM4EALDH1A1HPGDHTTL3MBTL1 | |
| SCHEMBL9524670 | 0.85 | NPC1 (0.46) | KDM4EALDH1A1HPGDHTTL3MBTL1 | |
| SCHEMBL9524673 | 0.85 | NPC1 (0.46) | KDM4EALDH1A1HPGDHTTL3MBTL1 | |
| SCHEMBL9524930 | 0.84 | RAB9A (0.46) | KDM4EALDH1A1HPGDL3MBTL1RARB | |
| SCHEMBL9524925 | 0.84 | RAB9A (0.46) | KDM4EALDH1A1HPGDL3MBTL1RARB | |
| SCHEMBL9084467 | 0.83 | KDM4E (0.42) | KDM4EALDH1A1HPGDHTTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0351746-B1 | Optically active 1,3-dioxolane derivatives containing a mesogene group in position 4, method for their preparation and their use as doping agents in liquid-crystal mixtures | HOECHST AG (DE) | 1993-12-29 | — | — | EP | disclosed |
| EP-0351746-A1 | Optically active 1,3-dioxolane derivatives containing a mesogene group in position 4, method for their preparation and their use as doping agents in liquid-crystal mixtures | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-01-24 | — | — | EP | disclosed |